Raymond James & Associates Aspira Women'S Health Inc. Transaction History

Raymond James & Associates

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$3.19 - $5.48 $96,420 - $165,638	-30,226 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$4.78 - $6.84 $4,780 - $6,840	1,000 Added 3.42%	30,226 $170,000
Q1 2021 May 14, 2021	BUY	$5.9 - $9.13 $12,036 - $18,625	2,040 Added 7.5%	29,226 $197,000
Q4 2020 Feb 12, 2021	SELL	$3.0 - $6.71 $3,000 - $6,710	-1,000 Reduced 3.55%	27,186 $182,000
Q3 2020 Nov 04, 2020	BUY	$2.54 - $4.56 $3,703 - $6,648	1,458 Added 5.45%	28,186 $87,000
Q2 2020 Jul 28, 2020	BUY	$0.78 - $5.25 $20,847 - $140,322	26,728 New	26,728 $103,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.